French quality-of-life questionnaire for meningioma patients
Part of Brain & nervous system, Cancer clinical trials.
This study tests a French version of a questionnaire that measures quality of life in people with meningioma. Participation involves filling out the questionnaire to help doctors better understand how the tumor affects your daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a meningioma (a type of brain tumor) confirmed by a scan or surgery.
- You are not pregnant or breastfeeding.
- You are not in prison, under guardianship, or receiving psychiatric care that limits your ability to decide.
- You can read and understand French well enough to complete a questionnaire.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to validate a French questionnaire about quality of life for people with meningiomas. By answering some questionnaires, you can help doctors better understand how this condition affects daily life.
This study measures how heart procedures affect quality of life for both patients and their caregivers, using simple questionnaires.
This study looks at how your tumor's genes, personal health habits, and other factors affect your long-term health after a meningioma diagnosis. You'll be asked to complete surveys about your health and experiences—no new treatments or procedures are involved.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
This study looks at how life quality changes in children and young adults after a new diagnosis of a brain germ cell tumor. It may help doctors understand which supports improve day-to-day well-being.
This study tests a questionnaire about quality of life for people with ovarian cancer. You will answer questions about your symptoms and well-being to help doctors better understand the patient experience.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.